Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
latest_posts
- 1
Most loved Web-based feature: Which Stage Do You Like - 2Dick Van Dyke shares his secrets to longevity as he turns 100
- 3Curl Up With Some Hot Chocolate And Watch Mighty Car Mods Explore Japan In A Honda City Turbo II
- 4Colorado residents face earliest water restrictions ever — a harbinger of worse to come
- 5Giude to Best Web based Learning Stage
- Gym tied to outbreak of obscure disease that spreads through mist
- Ocean side Objections: Staggering Waterfront Breaks
- A Manual for Pick Great Lawful Discussion Administrations For New businesses In 2024
- Kissing is an ‘evolutionary conundrum.’ Scientists just mapped its unexpected origins
- European Travel Objections for 2024
- Volkswagen Just Revealed a Massive Range-Extended SUV for China, and America Isn’t Getting It
- Middle East hotels hit pandemic-era lows amid Iran war
- Home Remodel Administrations: Change Your Residing Space
- Anthony Joshua's driver charged over Nigeria crash that killed two
